BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

5,342
Mkt Cap
$11.71B
Volume
798,971.00
52W High
$73.18
52W Low
$50.76
PE Ratio
34.17
BMRN Fundamentals
Price
$60.57
Prev Close
$60.89
Open
$60.26
50D MA
$59.07
Beta
0.71
Avg. Volume
2.43M
EPS (Annual)
$1.80
P/B
1.92
Rev/Employee
$1.01M
$10,813.39
Loading...
Loading...
News
all
press releases
BioMarin Pharmaceutical (NASDAQ:BMRN) Given New $85.00 Price Target at Bank of America
Bank of America decreased their price target on BioMarin Pharmaceutical from $97.00 to $85.00 and set a "buy" rating for the company in a report on Wednesday...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Korea Investment CORP
Korea Investment CORP grew its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 115.2% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·1d ago
News Placeholder
Do Options Traders Know Something About BMRN Stock We Don't?
Investors need to pay close attention to BioMarin Pharmaceutical stock based on the movements in the options market lately.
Zacks·2d ago
News Placeholder
BioMarin Pharmaceutical Inc. $BMRN Position Boosted by Vinva Investment Management Ltd
Vinva Investment Management Ltd grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 216.5% during the third quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
BioMarin Pharmaceutical Details Strategy Refresh, Voxzogo Competition and 40% Margin Goal at TD Cowen Confab
BioMarin Pharmaceutical (NASDAQ:BMRN) executives used a fireside chat at TD Cowen's 46th Annual Healthcare Conference to outline the company's refreshed strategy, discuss upcoming competitive...
MarketBeat·4d ago
News Placeholder
Elo Mutual Pension Insurance Co Purchases 22,851 Shares of BioMarin Pharmaceutical Inc. $BMRN
Elo Mutual Pension Insurance Co raised its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 97.1% in the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·7d ago
News Placeholder
BioMarin Pharmaceutical Inc. $BMRN Holdings Cut by Rafferty Asset Management LLC
Rafferty Asset Management LLC lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 12.0% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·9d ago
News Placeholder
BioMarin Pharmaceutical Inc. $BMRN Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 50.4% in the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·9d ago
News Placeholder
Andra AP fonden Acquires 105,000 Shares of BioMarin Pharmaceutical Inc. $BMRN
Andra AP fonden boosted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 282.3% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·10d ago
News Placeholder
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) U.S. Food and Drug Administration Approves...
PR Newswire·12d ago
<
1
2
...
>

Latest BMRN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.